Tocilizumab as a first-line biologic treatment in rheumatoid arthritis patients – the impact of concomitant methotrexate treatment and Rheumatic Disease Comorbidity Index on the clinical response – results from the multicenter observational ACT-POL study

Category Primary study
JournalReumatologia
Year 2022
This article has no abstract
Epistemonikos ID: 77bb232685cbdf9e108a7b92af87ca5c2ebc6aad
First added on: Feb 14, 2025